XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF EFFECTS OF THE RESTATEMENT TO AMOUNTS IN THE PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS

The following tables present the effects of the correction of the prior period error to the condensed consolidated statement of operations and comprehensive loss (in thousands, except for per share data):

 

             
   For the three months ended March 31, 2022 
Condensed Consolidated Statement of Operations and Comprehensive Loss  As Reported   Adjustment   As Revised 
             
Change in fair value of warrant liabilities  $   $(1,253)  $(1,253)
Net Loss  $(20,791)  $(1,253)  $(22,044)
Basic and diluted loss per common share  $(3.59)  $(0.21)  $(3.80)
Comprehensive loss  $(20,794)  $(1,253)  $(22,047)

 

 

The following tables present the effects of the correction of the prior period error to the condensed consolidated cash flow statement (in thousands):

 

   For the three months ended March 31, 2022 
Condensed Consolidated Cash Flow Statement  As Reported   Adjustment   As Revised 
             
Net Loss  $(20,791)  $(1,253)  $(22,044)
Adjustments to reconcile net loss to cash used in operating activities:               
Change in fair value of warrant liabilities  $   $(1,253)  $(1,253)
Net cash provided by operating activities  $(13,687)  $   $(13,687)

 

The following tables present the effects of the correction of the prior period error to the condensed consolidated statement of stockholders’ equity (in thousands):

 

   As of March 31, 2022 
Condensed Consolidated Statement of Stockholders’ Equity  As Reported   Adjustment   As Revised 
             
Additional paid-in capital, December 31, 2021  $705,570   $(9,007)  $696,563 
Total stockholders’ equity, December 31, 2021  $51,375   $(9,007)  $42,368 
Net Loss  $(20,791)  $(1,253)  $(22,044)
Additional paid-in capital, March 31, 2022  $706,433   $(9,007)  $697,426 
Total stockholders’ equity, March 31, 2022  $31,443   $(10,260)  $21,183 
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

   For the three months ended March 31, 
   2023   2022 
         
Stock options   234,697    284,072 
Restricted stock   929,946    77,945 
Warrants   9,397,879    1,788,000 
Total   10,562,522    2,150,017